Skip to content

BLO2D Unlimited

The effect of repeated exercise at high altitude on blood coagulation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29315
Enrollment
6
Registered
2017-03-05
Start date
2017-06-17
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High altitude Physical exercise Blood coagulation Thrombosis Extreme hoogte Lichamelijke ispanning Bloedstolling Trombose

Interventions

- Strenuous physical exercise (heart rate reserve 60-85%) during 2 hours, once at sea level (baseline) and repeated 3x at high altitude (3,883 m above sea level) - Venipuncture just before and immedi

Sponsors

Maastricht University Medical Center Synapse Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Healthy male volunteer - Age between 18 and 50 years old

Exclusion criteria

Exclusion criteria: - Previous history of cardiovascular disease, pulmonary disease, bleeding disorder or venous thromboembolism - Medication interfering with blood coagulation (low molecular weight heparins, vitamin K antagonists, direct oral anticoagulants, non-steroidal anti-inflammatory drugs) - Impaired mobility - Active smoking - Not passing medical assessment - Disapproval of contacting general practitioner in case of abnormalities found during medical assessment or during the study.

Design outcomes

Primary

MeasureTime frame
Trombin generation

Secondary

MeasureTime frame
- Plasmin generation - Platelet function test - Thromboelastometry - Blood count - Fibrinolysis (clot lysis time) - Coagulation factor analysis: von Willebrand factor (vWF), factor 8 (FVIII), D-dimers - Biochemical markers: lactate, creatinine, urea, albumin Other outcome parameters: - Age - Vital signs (heart rate, blood pressure and SpO2) - Questionnaire (Lake Louise AMS)

Contacts

Public ContactC.H. Kicken

Maastricht University Medical Center, department of Anesthesiology and Pain Therapy;

c.kicken@thrombin.com

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)